PRESS RELEASE published on 02/18/2025 at 18:52, 1 year 2 months ago Inside Information / Other news releases Medincell launches a Global Offering to expand its BEPO technology reach into new molecules and indications. Funds raised will strengthen licensing opportunities and improve shareholder structure Shareholder Structure Licensing Opportunities Medincell Global Offering BEPO Technology
BRIEF published on 02/06/2025 at 19:35, 1 year 2 months ago EIB Supports Medincell by Waiving Financial Covenants Loan Agreement Credit Facility Medincell Financial Covenants EIB
PRESS RELEASE published on 02/06/2025 at 19:30, 1 year 2 months ago Inside Information / Other news releases The EIB permanently waives two financial covenants in Medincell's loan agreement, showing confidence. €40M credit facility structure and key details explained Loan Agreement Credit Facility Medincell Financial Covenants EIB
BRIEF published on 01/29/2025 at 15:47, 1 year 3 months ago UZEDY® Achieves $117M in Sales in 2024 Teva Pharmaceuticals 2025 Projections UZEDY® Sales Medincell Partnership Olanzapine Injectable
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 3 months ago Inside Information / Other news releases UZEDY® sales reach $117M in 2024, surpassing Teva's expectations. Medincell poised for $160M in 2025 with Olanzapine Long-Acting Injectable near launch. Key partnership and financial insights Sales Partnership Medincell Teva Pharmaceuticals UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 4 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 4 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
BRIEF published on 11/28/2024 at 18:45, 1 year 5 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
BRIEF published on 11/22/2024 at 18:05, 1 year 5 months ago MedinCell: Update of share capital and voting rights Share Capital Voting Rights Euronext Actions Medincell
BRIEF published on 11/06/2024 at 13:47, 1 year 5 months ago Medincell: 2024 revenues on the rise and significant clinical progress Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
Published on 05/02/2026 at 01:30, 57 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 hour 37 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 2 hours 27 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 2 hours 27 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 3 hours 57 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 19:23, 7 hours 4 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 8 hours 42 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 9 hours 6 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 6 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 7 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 7 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 8 hours ago Minutes of the Combined General Meeting held on April 30, 2026
